-, Boston Park Plaza, Boston, MA
February 14-16, 2005
IBC’s 4th Preclinical Development Forum will provide you with in-depth information in the key areas of discovery and preclinical development that have the most impact on reducing the failure rate during clinical trials, including: pharmaceutical profiling, PK/PD, ADME, toxicology, biomarkers, in vivo/in vitro correlation, and animal models. The meeting takes an integrated learning approach which follows the way in which biotech and pharma are integrating the areas of early discovery, preclinical development and early clinical trials with the goal of addressing reasons for clinical trial failure earlier in the discovery and development phases. To register or view full conference details, visit www.IBCLifeSciences.com/pdf or call +1 508-616-5550 x1004.
|
|